Evidence map›Paper›PMID 31007743›Full record

ArticleExperimental and therapeutic medicine2019

H

Jianping Liu, Jianhua Li, Peigang Tian, Bahaer Guli, Guopeng Weng, Lei Li, Qinghong Cheng

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Utilising Network Pharmacology to Explore Underlying Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Inhibition of PI3K/mTOR/KArchives of pharmacal research · 2021
    Article
  15. Article
  16. Hydrogen Sulfide and the Immune System.Advances in experimental medicine and biology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jianping LiuDepartment of Critical Care Medicine, Medical School of Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Jianhua LiDepartment of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Peigang TianDepartment of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Bahaer GuliDepartment of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Guopeng WengDepartment of Critical Care Medicine, Medical School of Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Lei LiDepartment of Critical Care Medicine, Medical School of Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Qinghong ChengDepartment of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832008, P.R. China.
Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heart is the most vulnerable target organ in sepsis, and it has been previously reported that hydrogen sulfide (H

Indexed as

apoptosisH2Sinflammationmyocardial dysfunctionPI3K/Akt signalingsepsis

Identifiers

PMID31007743
PMCPMC6468938
OpenAlexW2923218404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.